Various vaccine platforms are geared against COVID-19 vaccine development to produce immunogens in cells.To design a recombinant protein-based COVID-19 vaccine,Vaxine pty Ltd used computer models of the spike protein ...Various vaccine platforms are geared against COVID-19 vaccine development to produce immunogens in cells.To design a recombinant protein-based COVID-19 vaccine,Vaxine pty Ltd used computer models of the spike protein and its human receptor,ACE2,to identify how the virus infects human cells.Based on this,the COVAX-19 ■vaccine is synthesized.It does reduce not only COVID-19 disease but also blocks virus shedding and transmission.Researchers are optimistic that this vaccine candidate could be clinically available soon with sufficient vaccine efficacy with a considerable amount of reduction in vaccination-related side effects.展开更多
文摘Various vaccine platforms are geared against COVID-19 vaccine development to produce immunogens in cells.To design a recombinant protein-based COVID-19 vaccine,Vaxine pty Ltd used computer models of the spike protein and its human receptor,ACE2,to identify how the virus infects human cells.Based on this,the COVAX-19 ■vaccine is synthesized.It does reduce not only COVID-19 disease but also blocks virus shedding and transmission.Researchers are optimistic that this vaccine candidate could be clinically available soon with sufficient vaccine efficacy with a considerable amount of reduction in vaccination-related side effects.
